Literature DB >> 35487968

Response to neoadjuvant endocrine therapy complements recurrence score.

Diana Romero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35487968     DOI： 10.1038/s41571-022-00641-1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   65.011


× No keyword cloud information.
  1 in total

1.  Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.

Authors:  Ulrike A Nitz; Oleg Gluz; Sherko Kümmel; Matthias Christgen; Michael Braun; Bahriye Aktas; Kerstin Lüdtke-Heckenkamp; Helmut Forstbauer; Eva-Maria Grischke; Claudia Schumacher; Maren Darsow; Katja Krauss; Benno Nuding; Marc Thill; Jochem Potenberg; Christoph Uleer; Mathias Warm; Hans Holger Fischer; Wolfram Malter; Michael Hauptmann; Ronald E Kates; Monika Gräser; Rachel Würstlein; Steven Shak; Frederick Baehner; Hans H Kreipe; Nadia Harbeck
Journal:  J Clin Oncol       Date:  2022-04-11       Impact factor: 50.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.